Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil

Introduction: Remifentanil followed by propofol provides adequate conditions for tracheal intubation without using muscle relaxants. Other hypnotic drugs have not been thoroughly evaluated in this regard. The purpose of this study was to assess intubating conditions and cardiovascular changes after...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/22972
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/22972
Palabra clave:
Anesthesia
Intratracheal
Intubation
Muscle relaxation
Rights
License
Abierto (Texto Completo)
id EDOCUR2_88c3cc4763b98505281e42ae8ad522de
oai_identifier_str oai:repository.urosario.edu.co:10336/22972
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 0f128505-eef5-412a-b04b-28000010a1d9-10d21312d-3252-44e0-85ba-80b71c1499fa-10271654f-020a-4124-86d9-0f5f44c5df8f-1189d2264-67a8-4b91-ac5a-a2bd7a38719a-12020-05-25T23:59:02Z2020-05-25T23:59:02Z2009Introduction: Remifentanil followed by propofol provides adequate conditions for tracheal intubation without using muscle relaxants. Other hypnotic drugs have not been thoroughly evaluated in this regard. The purpose of this study was to assess intubating conditions and cardiovascular changes after induction of anesthesia with remifentanil-propofol or. Methods: 90 ASA I/II patients were enrolled in this random, prospective, double-blind study. Subjects received 0.03 mg/kg of midazolam followed by a 7 ml/kg infusion of Ringe?s lactate. After that, 3 ?g/kg of remifentanil were injected followed by lydocaine, 1 mg/kg. Then, patients received either propofol (2 mg/ kg) (Propofol Group, n= 29), or etomidate (0.3 mg/kg) (Etomidate 3 Group, n=31) or etomidate (0.4 mg/kg) (Etomidate 4 Group, n=30). Subsequent laryngoscope and intubation were performed. Intubating conditions were assessed using a quality scoring system. Mean arterial pressure and heart rates pre-induction, post-induction were recorded immediately after intubation and every 1 to 5 minutes after intubation. Results: Three patients in the etomidate 3 Group and two patients in the etomidate 4 Group were not able to be intubated in the first attempt. Clinically acceptable intubating conditions were observed in 100%, 74%, 80% in the Propofol, Etomidate 3 and etomodate 4 groups, respectively (p=0.01 6). The decrease in mean arterial pressure was significantly higher in the propofol group as compared to the etomidate 3 group (p less than 0.05). Conclusions: The use of lydocaine-remifentanil-propofol for tracheal intubation without muscle relaxants is superior to 0.3 or 0.4 mg/kg lydocaine-remifentanil plus etomidate. However, etomidate 0.3 mg/kg produces a better hemodynamic profile when compared to propofol.application/pdf1203347https://repository.urosario.edu.co/handle/10336/22972spaSociedad Colombiana de Anestesiologia y Reanimacion SCARE129No. 2125Revista Colombiana de AnestesiologiaVol. 37Revista Colombiana de Anestesiologia, ISSN:1203347, Vol.37, No.2 (2009); pp. 125-129https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956495742&partnerID=40&md5=6c0a0a9b0a64efb23084efe273a274ecAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAnesthesiaIntratrachealIntubationMuscle relaxationOrotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanilIntubación orotraqueal sin relajante muscular: Propofol o etomidato en combinación con remifentaniloarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Rincón J.A.Hernández A.Charris H.Montes F.R.ORIGINALen_v37n2a04.pdfapplication/pdf371936https://repository.urosario.edu.co/bitstreams/2d2e4aa1-fcb9-4c52-b946-19b44d9fd124/downloadbdd5c9e16b13b4ec90bf12e26e56633bMD51TEXTen_v37n2a04.pdf.txten_v37n2a04.pdf.txtExtracted texttext/plain21870https://repository.urosario.edu.co/bitstreams/69e9013d-0919-49c9-bcef-561e53e5bb45/download67a8272f1caaa8d074f2abfb52d12603MD52THUMBNAILen_v37n2a04.pdf.jpgen_v37n2a04.pdf.jpgGenerated Thumbnailimage/jpeg3525https://repository.urosario.edu.co/bitstreams/d3e7ebbb-8a0f-4103-8cab-136b68a0a877/downloadb7f4db39f8d1242f3ecb65ef7c5e171cMD5310336/22972oai:repository.urosario.edu.co:10336/229722022-05-02 07:37:14.465859https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
dc.title.TranslatedTitle.spa.fl_str_mv Intubación orotraqueal sin relajante muscular: Propofol o etomidato en combinación con remifentanilo
title Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
spellingShingle Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
Anesthesia
Intratracheal
Intubation
Muscle relaxation
title_short Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
title_full Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
title_fullStr Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
title_full_unstemmed Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
title_sort Orotracheal intubation without the use of muscle relaxant: Propofol or etomidate in combination with remifentanil
dc.subject.keyword.spa.fl_str_mv Anesthesia
Intratracheal
Intubation
Muscle relaxation
topic Anesthesia
Intratracheal
Intubation
Muscle relaxation
description Introduction: Remifentanil followed by propofol provides adequate conditions for tracheal intubation without using muscle relaxants. Other hypnotic drugs have not been thoroughly evaluated in this regard. The purpose of this study was to assess intubating conditions and cardiovascular changes after induction of anesthesia with remifentanil-propofol or. Methods: 90 ASA I/II patients were enrolled in this random, prospective, double-blind study. Subjects received 0.03 mg/kg of midazolam followed by a 7 ml/kg infusion of Ringe?s lactate. After that, 3 ?g/kg of remifentanil were injected followed by lydocaine, 1 mg/kg. Then, patients received either propofol (2 mg/ kg) (Propofol Group, n= 29), or etomidate (0.3 mg/kg) (Etomidate 3 Group, n=31) or etomidate (0.4 mg/kg) (Etomidate 4 Group, n=30). Subsequent laryngoscope and intubation were performed. Intubating conditions were assessed using a quality scoring system. Mean arterial pressure and heart rates pre-induction, post-induction were recorded immediately after intubation and every 1 to 5 minutes after intubation. Results: Three patients in the etomidate 3 Group and two patients in the etomidate 4 Group were not able to be intubated in the first attempt. Clinically acceptable intubating conditions were observed in 100%, 74%, 80% in the Propofol, Etomidate 3 and etomodate 4 groups, respectively (p=0.01 6). The decrease in mean arterial pressure was significantly higher in the propofol group as compared to the etomidate 3 group (p less than 0.05). Conclusions: The use of lydocaine-remifentanil-propofol for tracheal intubation without muscle relaxants is superior to 0.3 or 0.4 mg/kg lydocaine-remifentanil plus etomidate. However, etomidate 0.3 mg/kg produces a better hemodynamic profile when compared to propofol.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:59:02Z
dc.date.available.none.fl_str_mv 2020-05-25T23:59:02Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.issn.none.fl_str_mv 1203347
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22972
identifier_str_mv 1203347
url https://repository.urosario.edu.co/handle/10336/22972
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.citationEndPage.none.fl_str_mv 129
dc.relation.citationIssue.none.fl_str_mv No. 2
dc.relation.citationStartPage.none.fl_str_mv 125
dc.relation.citationTitle.none.fl_str_mv Revista Colombiana de Anestesiologia
dc.relation.citationVolume.none.fl_str_mv Vol. 37
dc.relation.ispartof.spa.fl_str_mv Revista Colombiana de Anestesiologia, ISSN:1203347, Vol.37, No.2 (2009); pp. 125-129
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956495742&partnerID=40&md5=6c0a0a9b0a64efb23084efe273a274ec
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad Colombiana de Anestesiologia y Reanimacion SCARE
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/2d2e4aa1-fcb9-4c52-b946-19b44d9fd124/download
https://repository.urosario.edu.co/bitstreams/69e9013d-0919-49c9-bcef-561e53e5bb45/download
https://repository.urosario.edu.co/bitstreams/d3e7ebbb-8a0f-4103-8cab-136b68a0a877/download
bitstream.checksum.fl_str_mv bdd5c9e16b13b4ec90bf12e26e56633b
67a8272f1caaa8d074f2abfb52d12603
b7f4db39f8d1242f3ecb65ef7c5e171c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167445362966528